» Articles » PMID: 36175873

The Burden of Chronic Respiratory Disease and Attributable Risk Factors in North Africa and Middle East: Findings from Global Burden of Disease Study (GBD) 2019

Abstract

Background: North Africa and Middle East (NAME) has an increasing burden of chronic respiratory diseases (CRDs); however, a systematic understanding of the distribution and trends is not available. We aimed to report the trends of CRDs and attributable risk factors in this region between 1990 and 2019.

Methods: Using data from the Global Burden of Diseases Study (GBD) 2019, cause specific mortality served as the basis for estimating incidence and disability-adjusted life years (DALYs). The burden attributable to risk factors was calculated by a comparative risk assessment and contribution of population ageing and growth was determined by decomposition analysis.

Results: The number of deaths due to CRD in 2019 were 128,513 (110,781 to 114,351). In 2019, the age-standardized incidence rate (ASIR) of CRDs was 1052.8 (924.3 to 1209.4) per 100,000 population and had a 10.3% increase and the age-standardized death rate (ASDR) was 36.1 (30.9 to 40.3) with a 32.9% decrease compared to 1990. In 2019, United Arab Emirates had the highest ASIR (1412.7 [1237.3 to 1622.2]) and Afghanistan had the highest ASDR (67.8 [52.0 to 81.3]). CRDs were responsible for 2.91% of total DALYs in 2019 (1.69% due to chronic obstructive pulmonary disease [COPD] and 1.02% due to asthma). With regard to the components of DALYs, the age-standardized rate of years of life lost (YLL) had a - 39.0% (- 47.1 to - 30.3) decrease; while the age-standardized rate of years lived with disability (YLD) had a 13.4% (9.5 to 17.7) increase. Of total ASDRs of CRDs, 31.6% were attributable to smoking and 14.4% to ambient particulate matter pollution.

Conclusion: CRDs remain a leading cause of death and disability in NAME, with growth in absolute numbers. COPD and asthma were the most common CRDs and smoking was the leading risk factor especially in men. More attention is needed in order to reduce CRDs' burden through appropriate interventions and policies.

Citing Articles

The Saudi thoracic society guidelines for vaccinations in adult patients with chronic respiratory diseases.

Al Ghobain M, Farahat F, Zeitouni M, Alsowayan W, Al-Awfi S, AlBarrak A Ann Thorac Med. 2025; 20(1):36-48.

PMID: 39926401 PMC: 11804953. DOI: 10.4103/atm.atm_202_24.


Trends, seasonal variations and forecasting of chronic respiratory disease morbidity in charcoal producing areas, northwest Ethiopia: time series analysis.

Tesfa M, Motbainor A, Yenesew M Front Epidemiol. 2025; 4:1498203.

PMID: 39882567 PMC: 11774925. DOI: 10.3389/fepid.2024.1498203.


Trends in incidence, prevalence, and mortality of non-communicable diseases in Iraq (2003-2021).

Merzah M BMC Public Health. 2025; 25(1):374.

PMID: 39881276 PMC: 11780816. DOI: 10.1186/s12889-024-21080-w.


Joint association of systemic immune-inflammation index and phenotypic age acceleration with chronic respiratory disease: a cross-sectional study.

Zhan Y, Yang R, Feng J, Bai G, Shi X, Zhang J BMC Public Health. 2025; 25(1):186.

PMID: 39825391 PMC: 11740354. DOI: 10.1186/s12889-025-21430-2.


Burden of non-communicable diseases in Health Council of Gulf Cooperation (GCC) countries.

Alqadasi E, Chamroonsawasdi K, Saejeng K, Nagi M J Taibah Univ Med Sci. 2024; 19(4):877-884.

PMID: 39247447 PMC: 11380384. DOI: 10.1016/j.jtumed.2024.07.009.


References
1.
Fitzmaurice C, Allen C, Barber R, Barregard L, Bhutta Z, Brenner H . Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2016; 3(4):524-548. PMC: 6103527. DOI: 10.1001/jamaoncol.2016.5688. View

2.
. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396(10258):1223-1249. PMC: 7566194. DOI: 10.1016/S0140-6736(20)30752-2. View

3.
Alotaibi H, Alsanea N . Impact of taxation policy on tobacco consumption in Saudi Arabia. Ann Saudi Med. 2022; 42(1):1-7. PMC: 8812158. DOI: 10.5144/0256-4947.2022.1. View

4.
Zar H, Ferkol T . The global burden of respiratory disease-impact on child health. Pediatr Pulmonol. 2014; 49(5):430-4. DOI: 10.1002/ppul.23030. View

5.
Lai C, Beasley R, Crane J, Foliaki S, Shah J, Weiland S . Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax. 2009; 64(6):476-83. DOI: 10.1136/thx.2008.106609. View